In the last two decades, multidrug-resistant (MDR) microbial strains have been attributed to numerous infections worldwide. Regrettably, current treatment for these infections is severely limited, thus necessitating the development of novel prevention methods and therapeutics.
ATCC understands the danger and growing concern behind the spread of MDR strains. To aid in the prevention and treatment of MDR-associated infections, ATCC offers a complete set of solutions to advance your research:
- Drug-resistant microbial reference strains from various clinical and environmental sources
- Primary cells for drug toxicity screening studies
- Media and reagents to support cellular growth
All ATCC reference materials are produced under ISO 9001:2008 certified and ISO/IEC 17025:2005 accredited processes, ensuring reliability and reproducibility of research data. These strains are ideal for the development, verification, and evaluation of rapid detection methods, innovative therapeutic techniques, novel antibiotics, and updated sterility protocols.
FoodWorld 